Elderly men are more likely to be diagnosed with aggressive cancer, but are often inappropriately denied curative treatment. Biological rather than chronological age should be used to decide if a patient will profit from radical treatment. Therefore, every man aged >70 years should undergo a health assessment using a validated tool before making treatment decisions. Fit elderly men with intermediate- or high-risk disease should be offered standard curative local treatment in keeping with guidelines for younger men. Vulnerable and frail elderly men warrant geriatric intervention before treatment. In the case of vulnerable patients, this intervention may render them suitable for standard care. When considering radical prostatectomy outcomes a...
AbstractBackgroundMany elderly men with high-risk nonmetastatic prostate cancer (HRnMPCa) do not rec...
Purpose: To analyse tolerance and outcome of patients over 80 years of age who choose external beam ...
There is significant controversy on how aggressively to treat older men with prostate cancer. We ide...
Elderly men are more likely to be diagnosed with aggressive cancer, but are often inappropriately de...
Elderly men are likely to be diagnosed with clinically localized prostate cancer, however only few s...
Based on the exponential aging of the population and the increasing life expectancy in industrialize...
Given the demographic trends toward a considerably longer life expectancy, the percentage of elderly...
In 2010, the International Society of Geriatric Oncology (SIOG) developed treatment guidelines for m...
Purpose of reviewWith the pervasive use of prostate-specific antigen-based screening, many men in th...
It’s the most common cancer among men. Prostate cancer will affect one in five men at some point in ...
Background: Many elderly men with high-risk nonmetastatic prostate cancer (HRnMPCa) do not receive r...
Abstract Treatment guidelines recommend that curative radiation treatment of prostate cancer be offe...
Background: Elderly patients diagnosed with high-risk prostate cancer (PCa) present a therapeutic di...
Radical treatment of localized prostate cancer in elderly patients may lead to unacceptable treatmen...
PURPOSE: To discuss the issue of screening for prostate cancer in elderly individuals. The impact of...
AbstractBackgroundMany elderly men with high-risk nonmetastatic prostate cancer (HRnMPCa) do not rec...
Purpose: To analyse tolerance and outcome of patients over 80 years of age who choose external beam ...
There is significant controversy on how aggressively to treat older men with prostate cancer. We ide...
Elderly men are more likely to be diagnosed with aggressive cancer, but are often inappropriately de...
Elderly men are likely to be diagnosed with clinically localized prostate cancer, however only few s...
Based on the exponential aging of the population and the increasing life expectancy in industrialize...
Given the demographic trends toward a considerably longer life expectancy, the percentage of elderly...
In 2010, the International Society of Geriatric Oncology (SIOG) developed treatment guidelines for m...
Purpose of reviewWith the pervasive use of prostate-specific antigen-based screening, many men in th...
It’s the most common cancer among men. Prostate cancer will affect one in five men at some point in ...
Background: Many elderly men with high-risk nonmetastatic prostate cancer (HRnMPCa) do not receive r...
Abstract Treatment guidelines recommend that curative radiation treatment of prostate cancer be offe...
Background: Elderly patients diagnosed with high-risk prostate cancer (PCa) present a therapeutic di...
Radical treatment of localized prostate cancer in elderly patients may lead to unacceptable treatmen...
PURPOSE: To discuss the issue of screening for prostate cancer in elderly individuals. The impact of...
AbstractBackgroundMany elderly men with high-risk nonmetastatic prostate cancer (HRnMPCa) do not rec...
Purpose: To analyse tolerance and outcome of patients over 80 years of age who choose external beam ...
There is significant controversy on how aggressively to treat older men with prostate cancer. We ide...